New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine
- PMID: 37468688
- DOI: 10.1007/s10439-023-03321-y
New Solutions for Old Problems: How Reproductive Tissue Engineering Has Been Revolutionizing Reproductive Medicine
Abstract
Acquired disorders and congenital defects of the male and female reproductive systems can have profound impacts on patients, causing sexual and endocrine dysfunction and infertility, as well as psychosocial consequences that affect their self-esteem, identity, sexuality, and relationships. Reproductive tissue engineering (REPROTEN) is a promising approach to restore fertility and improve the quality of life of patients with reproductive disorders by developing, replacing, or regenerating cells, tissues, and organs from the reproductive and urinary systems. In this review, we explore the latest advancements in REPROTEN techniques and their applications for addressing degenerative conditions in male and female reproductive organs. We discuss current research and clinical outcomes and highlight the potential of 3D constructs utilizing biomaterials such as scaffolds, cells, and biologically active molecules. Our review offers a comprehensive guide for researchers and clinicians, providing insights into how to reestablish reproductive tissue structure and function using innovative surgical approaches and biomaterials. We highlight the benefits of REPROTEN for patients, including preservation of fertility and hormonal production, reconstruction of uterine and cervical structures, and restoration of sexual and urinary functions. Despite significant progress, REPROTEN still faces ethical and technical challenges that need to be addressed. Our review underscores the importance of continued research in this field to advance the development of effective and safe REPROTEN approaches for patients with reproductive disorders.
Keywords: Artificial organs; Engineered tissue; Fertility restoration; Regenerative medicine; Reproductive organs; Stem cells.
© 2023. The Author(s) under exclusive licence to Biomedical Engineering Society.
Similar articles
-
Recent Advancements in Engineered Biomaterials for the Regeneration of Female Reproductive Organs.Reprod Sci. 2021 Jun;28(6):1612-1625. doi: 10.1007/s43032-021-00553-y. Epub 2021 Apr 1. Reprod Sci. 2021. PMID: 33797052 Review.
-
Advances in biomaterials-based tissue engineering for regeneration of female reproductive tissues.Biofabrication. 2025 Feb 6;17(2). doi: 10.1088/1758-5090/adae38. Biofabrication. 2025. PMID: 39854843 Review.
-
Fibrin in Reproductive Tissue Engineering: A Review on Its Application as a Biomaterial for Fertility Preservation.Ann Biomed Eng. 2017 Jul;45(7):1650-1663. doi: 10.1007/s10439-017-1817-5. Epub 2017 Mar 7. Ann Biomed Eng. 2017. PMID: 28271306 Review.
-
Regenerative medicine for the treatment of reproductive system disorders: current and potential options.Adv Drug Deliv Rev. 2015 Mar;82-83:145-52. doi: 10.1016/j.addr.2014.10.019. Epub 2014 Oct 23. Adv Drug Deliv Rev. 2015. PMID: 25453265 Review.
-
Current status and challenges in uterine myometrial tissue engineering.Bioengineered. 2023 Dec;14(1):2251847. doi: 10.1080/21655979.2023.2251847. Bioengineered. 2023. PMID: 37665570 Free PMC article. Review.
Cited by
-
Infertility treatment using polysaccharides-based hydrogels: new strategies in tissue engineering and regenerative medicine.J Nanobiotechnology. 2025 Mar 4;23(1):162. doi: 10.1186/s12951-025-03267-4. J Nanobiotechnology. 2025. PMID: 40033394 Free PMC article. Review.
-
Multi-cellular engineered living systems to assess reproductive toxicology.Reprod Toxicol. 2024 Aug;127:108609. doi: 10.1016/j.reprotox.2024.108609. Epub 2024 May 16. Reprod Toxicol. 2024. PMID: 38759876 Free PMC article. Review.
-
Advances in Nanomedicine and Biomaterials for Endometrial Regeneration: A Comprehensive Review.Int J Nanomedicine. 2024 Aug 14;19:8285-8308. doi: 10.2147/IJN.S473259. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39161362 Free PMC article. Review.
-
Exploring the innovative application of cerium oxide nanoparticles for addressing oxidative stress in ovarian tissue regeneration.J Ovarian Res. 2024 Dec 5;17(1):241. doi: 10.1186/s13048-024-01566-2. J Ovarian Res. 2024. PMID: 39633503 Free PMC article. Review.
-
Bioengineered Cell Therapies for Endocrine Dysfunction: Advancements and Clinical Prospects.Endocr Metab Immune Disord Drug Targets. 2025;25(5):349-352. doi: 10.2174/0118715303311209240709115156. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39075961 No abstract available.
References
-
- Adamowicz, J., K. Juszczak, A. Bajek, J. Tworkiewicz, M. Nowacki, A. Marszalek, P. J. Thor, P. Chlosta, and T. Drewa. Morphological and urodynamic evaluation of urinary bladder wall regeneration: muscles guarantee contraction but not proper function—a rat model research study. Transplant Proc. 44:1429–1434, 2012. - PubMed - DOI
-
- Afshar, L., H.-R. Aghayan, J. Sadighi, B. Arjmand, S.-M. Hashemi, M. Basiri, R. O. Samani, M. K. Ashtiani, S.-A. Azin, and E. Hajizadeh-Saffar. Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran. Stem Cell Res. Ther. 11:1–5, 2020. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources